TY - JOUR
T1 - High-cost cancer treatment across borders in conflict zones
T2 - Experience of Iraqi patients in Lebanon
AU - Skelton, Mac
AU - Alameddine, Raafat
AU - Saifi, Omran
AU - Hammoud, Miza
AU - Zorkot, Maya
AU - Daher, Marilyne
AU - Charafeddine, Maya
AU - Temraz, Sally
AU - Shamseddine, Ali
AU - Mula-Hussain, Layth
AU - Saleem, Mohammed
AU - Namiq, Kazim F.
AU - Dewachi, Omar
AU - Sitta, Ghassan Abu
AU - Abdul-Sater, Zahi
AU - Telvizian, Talar
AU - Faraj, Walid
AU - Mukherji, Deborah
N1 - Publisher Copyright:
© 2020 by American Society of Clinical Oncology.
PY - 2020
Y1 - 2020
N2 - PURPOSE Conflict-induced cross-border travel for medical treatment is commonly observed in the Middle East. There has been little research conducted on the financial impact this has on patients with cancer or on how cancer centers can adapt their services to meet the needs of this population. This study examines the experience of Iraqi patients seeking care in Lebanon, aiming to understand the social and financial contexts of conflictrelated cross-border travel for cancer diagnosis and treatment. PATIENTS AND METHODS After institutional review board approval, 60 Iraqi patients and caregivers seeking cancer care at a major tertiary referral center in Lebanon were interviewed. RESULTS Fifty-four respondents (90%) reported high levels of financial distress. Patients relied on the sale of possessions (48%), the sale of homes (30%), and vast networks to raise funds for treatment. Thematic analysis revealed several key drivers for undergoing cross-border treatment, including the conflict-driven exodus of Iraqi oncology specialists; the destruction of hospitals or road blockages; referrals by Iraqi physicians to Lebanese hospitals; the geographic proximity of Lebanon; and the lack of diagnostic equipment, radiotherapy machines, and reliable provision of chemotherapy in Iraqi hospitals. CONCLUSION As a phenomenon distinct from medical tourism, conflict-related deficiencies in health care at home force patients with limited financial resources to undergo cancer treatment in neighboring countries. We highlight the importance of shared decision making and consider the unique socioeconomic status of this population of patients when planning treatment.
AB - PURPOSE Conflict-induced cross-border travel for medical treatment is commonly observed in the Middle East. There has been little research conducted on the financial impact this has on patients with cancer or on how cancer centers can adapt their services to meet the needs of this population. This study examines the experience of Iraqi patients seeking care in Lebanon, aiming to understand the social and financial contexts of conflictrelated cross-border travel for cancer diagnosis and treatment. PATIENTS AND METHODS After institutional review board approval, 60 Iraqi patients and caregivers seeking cancer care at a major tertiary referral center in Lebanon were interviewed. RESULTS Fifty-four respondents (90%) reported high levels of financial distress. Patients relied on the sale of possessions (48%), the sale of homes (30%), and vast networks to raise funds for treatment. Thematic analysis revealed several key drivers for undergoing cross-border treatment, including the conflict-driven exodus of Iraqi oncology specialists; the destruction of hospitals or road blockages; referrals by Iraqi physicians to Lebanese hospitals; the geographic proximity of Lebanon; and the lack of diagnostic equipment, radiotherapy machines, and reliable provision of chemotherapy in Iraqi hospitals. CONCLUSION As a phenomenon distinct from medical tourism, conflict-related deficiencies in health care at home force patients with limited financial resources to undergo cancer treatment in neighboring countries. We highlight the importance of shared decision making and consider the unique socioeconomic status of this population of patients when planning treatment.
UR - http://www.scopus.com/inward/record.url?scp=85079065220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079065220&partnerID=8YFLogxK
U2 - 10.1200/JGO.19.00281
DO - 10.1200/JGO.19.00281
M3 - Article
C2 - 32031440
AN - SCOPUS:85079065220
SN - 2378-9506
VL - 2020
SP - 59
EP - 66
JO - Journal of Global Oncology
JF - Journal of Global Oncology
IS - 6
ER -